A startup that's using stem cells from placentas for various regenerative medicine and cell therapy treatments just raised $250 million.
Celularity is a New Jersey-based company founded by X-Prize founder Dr. Peter Diamandis and veteran biotech executive Dr. Bob Hariri, who serves as CEO. The long-time friends put together a company that covers everything from storing the placental stem cells — a kind of cells that aren't specialized yet — to the development of treatments based on them.
The hope is that by using stem cells-based treatments for conditions like cancer and autoimmune disorders, people might be able to delay aging.
Celularity’s Massively Transformative Purpose (MTP) is to harness the power of the living cell to augment biology, immunity and longevity. Know more.